Cell Applications, Inc. have released six Gastrointestinal (GI) cell types for investigating epithelial cell physiology and associated GI tract diseases to support basic, translational and drug discovery research. A few highlights of our GI epithelial culture system includes;

  • Investigation of several disease indications such as GI infection, Inflammatory bowel disease (IBD), Ulcerative Colitis, Crohn’s Disease, Gastritis, and Gastric and Colon cancer. 
  • Epithelial cells derived from different areas of gastrointestinal tract.
  • GI epithelial in vitro culture model provides epithelial cell monolayer with a tight junction which is stable for up to a week in culture. 
  • Our epithelial cell culture system can be efficiently used as an R&D platform for screening and testing potential drug compounds, discovering new gastrointestinal disease modulators to study disease mechanisms.
  • Other applications GI model system include functional analysis of intestinal and gastric epithelium, tight junction function, GI disease modeling, and other cell-based validation assays. 
  • With CAI’s optimized, defined GI culture media, the epithelial cells can be seeded and maintained for as long as 8 days for evaluation of gene expression profiling, drug dosing and metabolism studies.


NEW: Cell Applications launches a biobank of Diseased Gastrointestinal Epithelial Cells from a diverse cohort of disease backgrounds. Learn More.